Novavax, Inc. (NVAX)
NASDAQ·Healthcare·Biotechnology
$7.96
-1.43%
Mkt Cap $1.33B
Analyst Ratings
Buy
3
Hold
1
Sell
1
Price Target (8 analysts)
$14.50
Range $11.00 – $18.00
Implied Upside
+82.3%
Consensus $14.50 vs current $7.96
NASDAQ·Healthcare·Biotechnology
$7.96
-1.43%
Mkt Cap $1.33B
Buy
3
Hold
1
Sell
1
Price Target (8 analysts)
$14.50
Range $11.00 – $18.00
+82.3%
Consensus $14.50 vs current $7.96